price down icon3.60%   -0.04
after-market  After Hours:  1.12  0.05   +4.67%

Why is Safety Shot Inc (SHOT) Stock down?

We've noticed a 7.94% decline in Safety Shot Inc (SHOT) stock during the 2024-05-24 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
13 Feb, 2024:

Safety Shot (SHOT) stock crashed by 23.62% on February 12, and continued to fall by 15.46% on the following day. This decline was mostly due to broader market trends. The market downturn occurred as data revealed that inflation had not eased as much as anticipated, with consumer prices rising by 3.1% in January compared to the previous year. While this marked a slowdown from December, it surpassed economists' expectations of a 2.9% increase.

  • Market Reaction and Investor Sentiment: The news on inflation did little to provide clarity on the Federal Reserve's potential actions regarding interest rates. Fed Chair Jerome Powell emphasized the need for further evidence that inflation is on track to meet the 2% target. Additionally, the market saw fluctuations in response to earnings reports, with Lyft shares surging after its results, while other companies like Coca-Cola reported mixed performances.
  • Key Market Indicators: The broader market experienced declines, with all three major U.S. stock indexes closing lower, led by the Nasdaq. The Dow industrials notably shed over 500 points. Despite these losses, all three indexes remained in positive territory for the year. Across sectors, the S&P 500 recorded declines, reflecting the widespread nature of the market downturn. Overall, Safety Shot's decline was part of broader market movements influenced by economic data and earnings reports, highlighting the interconnectedness of various factors impacting investor sentiment and stock performance.
22 Nov, 2023:

Safety Shot Inc. (SHOT) stock dropped by 25.47% due to warning issued by Safety Shot to its shareholders, which related to short sellers' activity.

  • Short Sellers' Activity: Safety Shot, Inc. addressed the presence of disclosed short sellers who were publishing what the company described as "malicious defamatory, inaccurate articles" about Safety Shot and its management. The company alleged that these short sellers aimed to scare SHOT investors into selling their shares, allowing the short sellers to cover their disclosed short positions at a lower cost.
  • Legal Actions Against Short Sellers: Safety Shot mentioned that several groups engaging in similar activities had faced legal actions and lawsuits in federal court for publishing fraudulent articles about other companies. They provided links to news articles reporting on lawsuits against short sellers.
  • Encouragement to Investors: The CEO of Safety Shot, Brian S John, encouraged investors to visit the company's events or corporate offices in Jupiter, Florida, to try Safety Shot for themselves. He also urged investors to conduct their own due diligence on the product and the company.
  • Retail Availability: Safety Shot announced plans to make its product available for retail purchase on their website and Amazon in December 2023. Additionally, they intended to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars in the first quarter of 2024. The warning from Safety Shot regarding short sellers and the legal actions against them likely raised concerns among investors, leading to the significant drop in the company's stock price on that particular trading day.
18 Sep, 2023:

Safety Shot Inc. (SHOT) stock dropped by 7.19% due to the company's announcement of its plan to develop a concentrated form of its Safety Shot beverage to treat alcohol poisoning in hospital and emergency settings. The innovative beverage, set to launch in Q4 2023, is designed to expedite recovery by reducing blood alcohol levels and improving mental clarity through four distinct mechanisms of action. With a focus on addressing the significant issue of alcohol poisoning, which leads to over 52 million emergency department admissions annually in the U.S., Safety Shot leverages its clinical development expertise and established infrastructure through its Jupiter Wellness segment to advance this groundbreaking solution, albeit prompting cautious investor sentiment given the complexities associated with medical applications of its product. Investors may have reacted cautiously to this announcement, leading to the decline in Safety Shot's stock price as they assessed the potential opportunities and challenges associated with this new development.

price up icon 0.85%
price down icon 1.78%
price down icon 2.08%
price down icon 1.00%
price down icon 0.36%
price down icon 3.75%
Cap:     |  Volume (24h):